Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

Stein Alexander; Petersen Volker; Schulze Mathias; Seraphin Joerg; Hoeffkes Heinz-Gert; Valdix Anette R.; Schroeder Jan; Herrenberger Julia; Boxberger Frank; Leutgeb Barbara; Hinke Axel; Kutscheidt Andreas; Arnold Dirk

首页> 外文期刊>Acta oncologica. >Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

【24h】

Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

机译：Bevacizumabplus化疗是转移性结直肠癌患者的一线治疗：一项来自德国社区的大型观察性队列研究的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. After approval of bevacizumab in Germany in 2005 for the treatment of unresectable advanced or refractory colorectal cancer (CRC), this observational cohort study was initiated to assess the efficacy and safety of bevacizumab with various chemotherapy regimen in patients with metastatic CRC (mCRC).

机译：背景。在2005年贝伐单抗在德国被批准用于治疗不可切除的晚期或难治性结直肠癌（CRC）后，这项观察性队列研究开始了评估贝伐单抗联合化疗方案对转移性CRC（mCRC）患者的疗效和安全性。

著录项

来源
《Acta oncologica.》 |2015年第6期|共8页
作者
Stein Alexander; Petersen Volker; Schulze Mathias; Seraphin Joerg; Hoeffkes Heinz-Gert; Valdix Anette R.; Schroeder Jan; Herrenberger Julia; Boxberger Frank; Leutgeb Barbara; Hinke Axel; Kutscheidt Andreas; Arnold Dirk;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study [J] . Stein Alexander, Petersen Volker, Schulze Mathias, Acta oncologica. . 2015,第1a6期

机译：Bevacizumabplus化疗是转移性结直肠癌患者的一线治疗：一项来自德国社区的大型观察性队列研究的结果
3. Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study [J] . Stein Alexander, Petersen Volker, Schulze Mathias, Acta oncologica. . 2015,第1a6期

机译：Bevacizumabplus化疗是转移性结直肠癌患者的一线治疗：一项来自德国社区的大型观察性队列研究的结果
4. Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results [J] . Ralf Hofheinz, Volker Petersen, Manfred Kindler, BMC Cancer . 2014,第1期

机译：贝伐单抗在老年转移性结直肠癌患者的一线治疗中：基于德国社区的观察性队列研究结果
5. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
6. Adherence to adjuvant chemotherapy and post-treatment surveillance in a large community-based cohort of patients with colon cancer. [D] . Hu, Chung-Yuan. 2010

机译：在结肠癌患者的大型社区队列中坚持辅助化疗和治疗后监测。
7. Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results [O] . Ralf Hofheinz, Volker Petersen, Manfred Kindler, 2014

机译：贝伐单抗在老年转移性结直肠癌患者的一线治疗中：基于德国社区的观察性队列研究结果
8. Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results [O] . 2014

机译：贝伐单抗在老年转移性结直肠癌患者的一线治疗中：基于德国社区的观察性队列研究结果

Bevacizumabplus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study

摘要

著录项

相似文献

相关主题

期刊订阅